MicroRNAs in Parkinson's disease

Experimental Brain Research
Abhishek Singh, Dwaipayan Sen

Abstract

Parkinson's disease is the second most common neurodegenerative disease commonly affecting the older population. Loss of dopaminergic neurons in the substantia nigra of brain leads to impairment of motor activities as well as cognitive defects. There are many underlying causes to this disease, both genetic and epigenetic, which are yet to be fully explored. Non-coding RNAs are significant part of our genome and are involved in various cellular processes. MicroRNAs, which are small non-coding RNAs having 20-22 nucleotides, are involved in many underlying mechanisms of pathogenesis of several neurodegenerative diseases including Parkinson's. This review focuses on the role played by microRNAs in regulating various genes responsible for the onset and pathogenesis of Parkinson's disease and various literature evidences pointing at the usefulness of targeting specific microRNAs as a potential alternate therapeutic strategy for successful impairment of the disease progression. This review also discusses about various biofluid-based microRNA markers which may be potentially utilized for diagnostic purposes.

References

Aug 1, 1990·Trends in Biochemical Sciences·J F Dice
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
Mar 27, 1999·The Journal of Biological Chemistry·L NarhiM Citron
Apr 29, 1999·Journal of Neuroscience Research·A H StokesK E Vrana
Oct 18, 2000·Biochemical and Biophysical Research Communications·S OhmachiN Itoh
Jun 11, 2002·Annual Review of Nutrition·Nathan E Hellman, Jonathan D Gitlin
Aug 3, 2002·Science·György Hutvágner, Phillip D Zamore
Feb 4, 2003·Journal of Neurochemistry·Hardy J RideoutLeonidas Stefanis
Feb 20, 2003·RNA·Victor AmbrosThomas Tuschl
Feb 26, 2003·Genes & Development·John G DoenchPhillip A Sharp
May 23, 2003·The Journal of Biological Chemistry·Xiao Tao, Liang Tong
Aug 27, 2003·The Journal of Biological Chemistry·Sun-Joo LeeSun-Shin Cha
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Feb 3, 2004·Annals of Neurology·Juan J ZarranzJusto G de Yebenes
Mar 27, 2004·The Journal of Biological Chemistry·Jochen KluckenPamela J McLean
Jun 24, 2004·Nature Reviews. Genetics·Lin He, Gregory J Hannon
Aug 11, 2004·Molecular Aspects of Medicine·Michael R Duchen
Nov 16, 2004·Neuron·Coro Paisán-RuízAndrew B Singleton
Apr 5, 2005·Nature Genetics·Azra KrekNikolaus Rajewsky
Jun 21, 2005·Current Biology : CB·Eric C Lai
Jul 19, 2005·Annual Review of Neuroscience·Darren J MooreTed M Dawson
Aug 23, 2005·FEBS Letters·Erno Wienholds, Ronald H A Plasterk
Nov 26, 2005·Science·Kyle Kai-How FarhDavid P Bartel
Feb 24, 2006·Nature Reviews. Neuroscience·Patrick M Abou-SleimanNicholas W Wood
Mar 7, 2006·The Journal of Biological Chemistry·Joungil ChoiLian Li
Nov 23, 2006·Nature Reviews. Neuroscience·Kenneth S Kosik
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Günter U HöglingerStéphane Hunot
Sep 1, 2007·Science·Jongpil KimAsa Abeliovich
Sep 13, 2007·PloS One·Thomas HansenThomas Werge
Dec 20, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Nathan Pankratz, Tatiana Foroud
Mar 18, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·J Jankovic

❮ Previous
Next ❯

Citations

Jan 22, 2019·Journal of Cellular Biochemistry·Mohammad Saeed ManiatiSadra Samavarchi Tehrani
Apr 17, 2019·Annals of Neurology·Jessica SchulzChristina M Lill
Aug 2, 2017·Journal of Alzheimer's Disease : JAD·Ratko RadakovicSharon Abrahams
Jun 18, 2020·The International Journal of Neuroscience·Betul Ozdilek, Berna Demircan
Jun 15, 2018·International Journal of Molecular Medicine·Yunlu JiangBo Bai
Feb 23, 2020·Frontiers in Aging Neuroscience·Alexandre IarkovValentina Echeverria
Mar 16, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Melissa R PergandeStephanie M Cologna
Oct 20, 2018·International Journal of Molecular Sciences·Oscar Teijido, Ramón Cacabelos
Jun 4, 2019·Frontiers in Pharmacology·Svetlana Miroshnichenko, Olga Patutina
Jun 30, 2019·International Journal of Molecular Sciences·Takashi HosakaShin Kwak
Oct 13, 2017·Frontiers in Molecular Neuroscience·Destiny-Love ManeckaThomas M Durcan
May 1, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ping SunKe-Jie Yin
Sep 30, 2018·Neurochemical Research·Camila Hillesheim HorstRicardo Titze-de-Almeida
Jun 2, 2020·Frontiers in Cellular Neuroscience·Ximena Paez-ColasanteEva L Feldman
Jul 14, 2020·Frontiers in Neuroscience·Shane V HegartyAideen M Sullivan
Aug 25, 2020·Journal of Cardiovascular Pharmacology·Jinjing ChenLiang Gu
Feb 4, 2021·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Maria IzcoLydia Alvarez-Erviti
Oct 30, 2020·Neuropsychiatric Disease and Treatment·Yong-Ping LiuBao-Jie Wang
Mar 23, 2021·Frontiers in Cell and Developmental Biology·Elisabeth FindeissGünter U Höglinger
Apr 17, 2021·Frontiers in Genetics·Saltanat KamenovaAnatoliy Ivashchenko

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
transgenic
PCR

Software Mentioned

TargetScan

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.